Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

    Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

    Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

    Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

    AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

    AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

    EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

    EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

    EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

    Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

    Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

    US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

    US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

    Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

    Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

    Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

    Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

    Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

    AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

    AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

    EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

    EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

    EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

    Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

    Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

    US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

    US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

    Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

    Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

TrakCel, WindMIL Therapeutics Partner to Develop Supply Chain Platform

Content Team by Content Team
8th February 2019
in Manufacturing, News
TrakCel, WindMIL Therapeutics Partner to Develop Supply Chain Platform

TrakCel—a software developer for cell and gene therapy supply chain tracking and orchestration systems—and WindMIL Therapeutics—a clinical-stage oncology cell therapy company—have formed a partnership to build a custom-configured cellular supply chain tracking and orchestration platform.

The platform will support the clinical development of proprietary autologous cell therapies from WindMIL and will also be used to manage the company’s entire supply chain. This clinical expansion by WindMIL follows its successful completion of a Series B financing round, in which it raised US$32.5 million in June 2018.

“We are excited to soon treat more patients with Marrow Infiltrating Lymphocytes(MILs) through this expansion of our clinical trial program. MILs harness the power of the body’s own immune system, specifically cells residing in the bone marrow. We are the only company focused on manufacturing and developing this natural source of tumor-targeting, central-memory T cells,” said Brian Halak, president and CEO, WindMIL Therapeutics in a Jan. 29, 2019, press release. “However, developing novel cellular therapies is also about logistics. It is important for us to ensure the supply chain works for each of the individuals involved in the patient’s care and for the oncology patients themselves.”

“The entire cell therapy sector now realizes the importance of managing and tracking the supply chain from an early stage. As a result, TrakCel is now working with a range of companies at the initiation of the clinical stage as well as at the late stage of clinical development,” said Ravi Nalliah, CEO of TrakCel.

Previous Post

Enzene Biosciences Chooses Novasep BioSC Pilot Chromatography for Its Automated End to End Continuous Manufacture of mAb

Next Post

IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

Related Posts

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8
Drug Development

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

21st February 2019
Medicine’s just the beginning: eyeforpharma Barcelona 2019 is at record attendance this is going to be the greatest one yet
Manufacturing

Medicine’s just the beginning: eyeforpharma Barcelona 2019 is at record attendance this is going to be the greatest one yet

20th February 2019
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership
Manufacturing

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

13th February 2019
AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma
Drug Development

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

13th February 2019
U.S. FDA Approves DARZALEX Split-Dosing Regimen
FDA Approvals

U.S. FDA Approves DARZALEX Split-Dosing Regimen

13th February 2019
EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
FDA Approvals

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

12th February 2019
Next Post
IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

Latest News

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8
Drug Development

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

21st February 2019
Medicine’s just the beginning: eyeforpharma Barcelona 2019 is at record attendance this is going to be the greatest one yet
Manufacturing

Medicine’s just the beginning: eyeforpharma Barcelona 2019 is at record attendance this is going to be the greatest one yet

20th February 2019
Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials
Clinical Trials

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

13th February 2019
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership
Manufacturing

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

13th February 2019
AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma
Drug Development

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

13th February 2019
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Market Moves OLD
  • Manufacturing
  • News
  • Events & Conferences

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Download Media Pack

Close

x
No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In